"uuid:ID","identifier","name","id","description","text","instanceType","label"
"c1bd251b-1fea-4cbe-af76-5ece3a7c4951","1","Age Criteria","EligibilityCriterion_1","The study age criterion","Subjects shall be between [min_age] and [max_age]","EligibilityCriterion",""
"78383f4c-9573-4cdd-9e13-090f175a0034","2","Pop Criteria","EligibilityCriterion_2","The study population criterion","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)","EligibilityCriterion",""
"b8abe741-dab8-4da5-9d22-01e76ab195fe","3","Diag Criteria","EligibilityCriterion_3","The study diagnosis criterion","[Activity1] score of 10 to 23","EligibilityCriterion",""
"2854c3b6-773f-4b8d-8eb3-556ad07e78fd","9","Previous Criteria","EligibilityCriterion_4","The previous xanomeline TTS criterion","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline.","EligibilityCriterion",""
